Phibro Animal Health Corp (PAHC): Capital Expenditures
$59.09M
Year ended 2026-06-30
+4.5%
3-year compound annual growth
+15.0%
5-year compound annual growth
+5.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $59.09M | +54.3% | 2026-08-26, From 2025-07-01 |
| 2025-06-30 | $38.29M | -7.1% | 2026-08-26, From 2024-07-01 |
| 2024-06-30 | $41.24M | -20.4% | 2026-08-26, From 2023-07-01 |
| 2023-06-30 | $51.79M | +39.8% | 2025-08-27, From 2022-07-01 |
| 2022-06-30 | $37.04M | +26.3% | 2024-08-28, From 2021-07-01 |
| 2021-06-30 | $29.32M | -13.9% | 2023-08-30, From 2020-07-01 |
| 2020-06-30 | $34.05M | +13.9% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $29.89M | +61.2% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $18.55M | -11.2% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $20.88M | -42.6% | 2019-08-27, From 2016-07-01 |
| 2016-06-30 | $36.35M | +81.2% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $20.06M | +1.1% | 2017-08-30, From 2014-07-01 |
| 2014-06-30 | $19.85M | -0.5% | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | $19.95M | +34.6% | 2015-09-10, From 2012-07-01 |
| 2012-06-30 | $14.82M | n/a | 2014-09-18, From 2011-07-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $59.09M | +54.3% |
| Alkermes plc. (ALKS) | 2025-12-31 | $40.42M | +20.7% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $8.86M | +36.3% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $66.00M | +127.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $101.97M | -25.5% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
Compare PAHC, ALKS, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗